Corrigendum to "Re: Pathologic complete responses, long-term outcomes, and recurrence patterns in HER2-low vs. HER2-zero breast cancer after neoadjuvant chemotherapy: Several issues about HER2 expression and neoadjuvant chemotherapy in breast cancer" [Eur J Cancer 180 (2023) 184-185].

Eur J Cancer

Department of Liver Surgery, Peking Union Medical College Hospital, China; Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. Electronic address:

Published: March 2024

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ejca.2024.113559	DOI Listing

Publication Analysis

neoadjuvant chemotherapy

corrigendum "re

"re pathologic

pathologic complete

complete responses

responses long-term

long-term outcomes

outcomes recurrence

recurrence patterns

patterns her2-low

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!